Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
American Journal of Biochemistry and Molecular Biology
  Year: 2012 | Volume: 2 | Issue: 3 | Page No.: 195-199
DOI: 10.3923/ajbmb.2012.195.199
Tissue Inhibitors of Matrix Metalloproteinase-3, Potential Therapeutic Target against Multiple Sclerosis
Amir Ghaemi, Kasra Hamdi, Mansoureh Togha, Hadi Kazemi and Ali Gorji

Abstract:
The Matrix Metalloproteinase Proteins (MMPs) comprise a large group of endoproteinases that cleave most, if not all, components of the extracellular matrix. The activities of MMPs are modulated by manipulation in the levels of natural MMP inhibitors, the “Tissue Inhibitors of Metallo Proteinases” (TIMPs). In a pathological processes of Multiple Sclerosis (MS), the MMP-2 and 9 (Gelatinase) are over expressed and balance of TIMP and MMP expression is perturbed, leading to locally increased proteolytic activity of Gelatinase and uncontrolled degradation of the Blood Brain Barrier (BBB) and myelin basic protein. Therefore, Gelatinase are the main mediators in the evolution of MS and TIMP has been proposed as a novel therapeutic target for MS therapy.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Lambda Phage Nanoparticles for Targetomics
  •    AT1 Receptors Activation Enhances the Expression of MMP-2, MMP-13 and VEGF but not MMP-9 in B16F10 Melanoma Cells
  •    MMP-13 Inhibitory Activity of Thirteen Selected Plant Species from Okinawa
  •    Effects of Interferon-γ Gene Therapy in the Murine Central Nervous System and Concentrations in Cerebrospinal Fluid after Intrathecal or Intracerebral Administration
  •    Expressions of Epidermal Growth Factor Receptor, Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Bladder Carcinoma
How to cite this article:

Amir Ghaemi, Kasra Hamdi, Mansoureh Togha, Hadi Kazemi and Ali Gorji, 2012. Tissue Inhibitors of Matrix Metalloproteinase-3, Potential Therapeutic Target against Multiple Sclerosis. American Journal of Biochemistry and Molecular Biology, 2: 195-199.

DOI: 10.3923/ajbmb.2012.195.199

URL: https://scialert.net/abstract/?doi=ajbmb.2012.195.199

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 

       

       

Curve Bottom